All companies
Visit website
CERN Corporation
OperatingCern Corporation
Healthcare · Founded 2016
Microbicidal light treatment for fungal & bacterial vaginosis
Post-money valuation ⓘ
$12.4M
As of Apr 2023 · from CERN Corporation Common Stock 1 · pre-money + amount raised, not a traded price
Total raised
$370,399
Across 1 round since 2022
Latest share price
$0.80
CERN Corporation Common Stock 1 offering price
Financials
FY2020–FY2023 · from SEC filings · hover any figure for its source$0
−$74K
2020
$0
2021
$0
−$112K
2022
$0
−$221K
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
FY2022
FY2023
Income statement
Revenue
$0
$0
$0
$0
Cost of goods sold
$0
$0
$111,343
$220,573
Net income
-$73,704
$0
-$111,759
-$220,637
Taxes paid
$0
$0
$0
$2,123
Balance sheet
Cash
$8,834
$8,964
$219,757
$173,972
Accounts receivable
$0
$0
$0
$0
Total assets
$8,834
$8,964
$219,757
$173,972
Short-term debt
$139,896
$34,093
$84,546
$84,682
Long-term debt
$0
$37,207
$84,546
$84,682
Total liabilities
$139,896
$71,300
$169,091
$169,364
Other
Headcount
—
1
1
1
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$12.4M
post-money
CERN Corporation Common Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $370.4K / $1.1MInvestors 72Post-money $12.4M
Reg CF annual-report compliance
Not requiredFiled Form C-TR (terminated reporting)
Filed 2 of 4 annual reports (FY2022–FY2025)
72 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001942093Share price $0.80
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.